Key result
Trans-jugular ASD closure with a steerable introducer achieves 100% procedural success without early complications.
Why the study?
A novel surgical approach for percutaneous trans-jugular vein closure of atrial septal defect with steerable introducer under echocardiographic guidance was developed to improve ease of operation and reduce damage.
Does percutaneous trans-jugular vein closure with a steerable introducer safely and effectively close atrial septal defects in patients with ASD?
Observational (n=10)
Does percutaneous trans-jugular vein closure with a steerable introducer safely and effectively close atrial septal defects in patients with ASD?
Percutaneous trans-jugular vein closure of ASD using a steerable introducer under echocardiographic guidance appears to be a feasible and safe novel approach.
Answers are grounded in this paper and cite their sources.
May support trans-jugular ASD closure feasibility in small series; leaves open need for larger trials before clinical adoption.
BACKGROUND: The aim of this study is to discuss a novel surgical approach of percutaneous trans-jugular vein closure of atrial septal defect (ASD) with steerable introducer under echocardiographic guidance. METHODS: From January 2015 to June 2015, ten ASD patients underwent percutaneous trans-jugular vein ASD closure, the occluder placement could be perpendicular to the plane of ASD using the steerable introducer. RESULTS: All cases succeeded. The average procedure time was 27.4±5.6 minutes; and the average intracardiac operation time was 6.7±5.2 minutes. No patient showed the residual shunt after the procedure. There was no clinical death, no arrhythmia, no hemolysis, no infection, no jugular vein damage or occlusion during patients' hospitalization. The post-operation follow up after one month of the operation showed that there was no residual shunt, no falling off or detachment of occluders or other complications. CONCLUSIONS: It is a new surgical method with easy operation, mild damage and wider indication. Compared with the traditional percutaneous and transthoracic closure of ASD, it has obvious advantages.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2015) conducted an observational in Atrial septal defect (n=10). Percutaneous trans-jugular vein closure of ASD with steerable introducer under echocardiographic guidance was evaluated on Procedural success.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: